|
Wednesday, November 18, 2015
Print Current Session:
 |
|
|
Wednesday
SESSION 24:
MORE LOWER EXTREMITY HOT TOPICS AND NEW DEVELOPMENTS
Moderators:Giancarlo Biamino, MD, PhD / Kenneth Ouriel, MD, MBA
|
|
| SESSION 24 SCHEDULE | |
| 7:46 AM - 7:51 AM | Comparison Of Tibial Bypasses With Saphenous Vein vs. Heparin Bonded PTFE (Propaten): Current Indications For Prosthetic Tibial Bypasses And New Developments For Limb Salvage |
| Presenter(s):Richard F. Neville, MD | |
| View Slides in PDF | |
| 7:52 AM - 7:57 AM | In Patients With Extensive Gangrene From CLI (Rutherford 5 And 6), Limited Vein And Occlusive Disease Of The SFA And Distal Arteries, Endovascular Treatment Of The SFA And A Short Vein Distal Bypass Is The Best Way To Achieve Limb And Patient Survival |
| Presenter(s):Francesco Spinelli, MD | |
| View Slides in PDF | |
| 7:58 AM - 8:03 AM | Below The Ankle And Perimalleolar Occlusive Disease With CLI: Tips And Tricks For Treating It Endovascularly And When They Should Be Used: Hydrodynamic Boost To Re-Enter The Tibial Artery True Lumen And Venous Arterialization |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 8:04 AM - 8:09 AM | New Tips, Tricks And Devices For Pedal And Other Distal Access Procedures |
| Presenter(s):Andrej Schmidt, MD | |
| View Slides in PDF | |
| DRUG ELUTING BALLOONS (DEBS) | |
| 8:10 AM - 8:15 AM | Importance Of Trial Design And Other Factors In Evaluating The Differing Results With DEBs |
| Presenter(s):Kenneth Rosenfield, MD | |
| View Slides in PDF | |
| 8:16 AM - 8:21 AM | Under What Conditions Should DEBs Be Used Preferentially: Diabetics, Calcified Lesions, Extensive Foot Necrosis: What Does It Take To Make DEBs Work Optimally |
| Presenter(s):Francesco Liistro, MD | |
| View Slides in PDF | |
| 8:22 AM - 8:27 AM | 2-Year Results With The Lutonix (Bard) DEB vs. Uncoated Balloon Angioplasty (POBA): The LEVANT II Trial In The SFA And BTK Lesions |
| Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD / Kenneth Rosenfield, MD / Marianne Brodmann, MD / Thomas Zeller, MD | |
| View Slides in PDF | |
| 8:28 AM - 8:33 AM | In Femoropopliteal Stenting Does Drug Elution Make A Difference vs. Uncoated Stents: New Data From The MAJESTIC Trial |
| Presenter(s):Stefan Mueller-Huelsbeck, MD | |
| View Slides in PDF | |
| 8:34 AM - 8:39 AM | Access For BTK Interventions Via Puncture Through Totally Occluded SFAs (With Or Without A Previous Stent): How To Do It |
| Presenter(s):Luigi Inglese, MD | |
| 8:40 AM - 8:45 AM | What The Surgeon Should NOT Do To Preserve Options For Future Endovascular Therapy And Vice Versa |
| Presenter(s):Sigrid Nikol, MD | |
| View Slides in PDF | |
| 8:46 AM - 8:52 AM | Panel Discussion |
| END OF SESSION 24 | |
| previous | next |